Location History:
- Wilts, GB (2014)
- Parma, IT (2004 - 2022)
Company Filing History:
Years Active: 2004-2022
Title: David Andrew Lewis: Innovator in Pharmaceutical Solutions
Introduction
David Andrew Lewis is a prominent inventor based in Parma, Italy, recognized for his contributions to the field of pharmaceutical formulations. With an impressive portfolio of 17 patents, Lewis has continually worked towards advancing medical technologies and improving patient outcomes.
Latest Patents
One of Lewis's latest inventions includes the development of pharmaceutical solution formulations for pressurized metered dose inhalers. This innovation focuses on the prevention and treatment of severe broncho-pulmonary diseases by administering a solution formulation that contains two or more fully dissolved active drug substances. This method ensures that both substances are delivered with a similar particle size distribution, enhancing their therapeutic effectiveness.
Additionally, Lewis has invented an aerosol inhalation device that features novel actuators. These actuators consist of a housing designed to hold an aerosol canister containing a pressurized medicament formulation, along with a mouthpiece, nozzle block, and orifice. The inclusion of a tubular element in the mouthpiece significantly reduces the non-respirable, coarse fraction of the emitted aerosol, consequently minimizing side effects and oral candidiasis in patients while maintaining the fine particle dose characteristics.
Career Highlights
David Andrew Lewis is currently employed at Chiesi Farmaceutici S.p.A., a global pharmaceutical company specializing in respiratory therapies. His work has garnered attention for its focus on innovation in drug delivery mechanisms, particularly for respiratory conditions.
Collaborations
Throughout his career, Lewis has collaborated with esteemed colleagues such as Gaetano Brambilla and Brian John Meakin. Together, they have pursued research and development initiatives aimed at enhancing therapeutic interventions and patient care.
Conclusion
David Andrew Lewis's contributions to the field of pharmaceutical science through his innovative patents reflect a commitment to improving treatments for patients with respiratory diseases. His work at Chiesi Farmaceutici S.p.A., combined with his collaborative efforts, positions him as a leading figure in the advancement of inhalation therapies.